PPARGC1A and Wilson disease: We found that expression levels of the PPARα cofactor Ppargc1a were increased in WDPQQ (p = 0.0504 vs. WD) and the downstream target Acadm was markedly increased in WDPQQ/WD (p = 0.006 vs. WD).